杨聪金

All filings by 杨聪金 on record concern 鹭燕医药, in the capacity of board member. In total, 3 filings cover trades dated from 10 December 2021 to 27 September 2023.

Every open-market trade on record is a sale: 3 sales worth €373k. So far in 2023, the count stands at no purchases and 1 sale.

On 27 September 2023 came the latest disclosure, an open-market sale for €132k in 鹭燕医药. Publication is fast: at least half of the trades appear on SSE / SZSE (CSRC) on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.